NSRS Stock Overview
Medcann Industries, Inc. focuses on the manufacture and assembly of medicines, cosmetics, and health treatment products and drinks.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Medcann Industries, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -98.48% |
| 5 Year Change | -98.33% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NSRS | US Metals and Mining | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | 0.3% |
| 1Y | n/a | 18.6% | 26.2% |
Return vs Industry: Insufficient data to determine how NSRS performed against the US Metals and Mining industry.
Return vs Market: Insufficient data to determine how NSRS performed against the US Market.
Price Volatility
| NSRS volatility | |
|---|---|
| NSRS Average Weekly Movement | n/a |
| Metals and Mining Industry Average Movement | 8.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NSRS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NSRS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | John Vivian | medcannindustries.com |
Medcann Industries, Inc. focuses on the manufacture and assembly of medicines, cosmetics, and health treatment products and drinks. The company was formerly known as North Springs Resources Corp. and changed its name to Medcann Industries, Inc. in January 2023. Medcann Industries, Inc. was founded in 2009 and is based in Riverview, Florida.
Medcann Industries, Inc. Fundamentals Summary
| NSRS fundamental statistics | |
|---|---|
| Market cap | US$15.90k |
| Earnings (TTM) | -US$7.80k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs NSRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSRS income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$7.80k |
| Earnings | -US$7.80k |
Last Reported Earnings
Apr 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NSRS perform over the long term?
See historical performance and comparison